ARGX argenx SE

$984.39▲ +0.04% Healthcare Other
After hours $1,000.00▲ +1.59% Sep 11, 7:43 PM ET
Volume 181.9K Avg Volume (10D) 222.2K
Key Metrics & Fundamentals
Market Cap
$61.22B
P/E Ratio
37.5
Div Yield
–%
52W Range
661.85 - 1072.75
% vs 50 MA
5.60%
% vs 200 MA
16.34%
RSI-14
50.3
MACD Histogram
-10.1800
Beta (1Y vs SPY)
0.35
Gross Rev
$1.52B
Gross Profit
$1.37B
EBITDA
$541.00M
COGS
$145.00M
Operating Exp
$876.00M
Operating Income
$494.00M
EBIT
$494.00M
Pretax Income
$532.00M
Net Income
$472.00M
Price & Volume History
Loading chart…
Recent News
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT Newswires · Sep 8, 2026 3:28 PM
BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery
Business Wire · Sep 2, 2026 12:00 PM
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?
Motley Fool · Sep 2, 2026 9:04 AM
argenx to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 5:00 AM
A single drug made Argenx one of the most valuable biotechs in Europe. Its new CEO is ready for the next act.
Pharma Voice · Aug 28, 2026 9:16 AM
argenx (ENXTBR:ARGX) Stock Looks Rich Despite Its 210% Five Year Run
Simply Wall St. · Aug 28, 2026 8:20 AM
argenx (ENXTBR:ARGX) Just Gave Investors Something To Think About
Simply Wall St. · Aug 28, 2026 12:15 AM
Argenx (ENXTBR:ARGX) Completes Forte Biosciences Acquisition
Simply Wall St. · Aug 27, 2026 5:08 PM
Argenx Completes Acquisition of Forte Biosciences
MT Newswires · Aug 27, 2026 1:09 PM
argenx Completes Acquisition of Forte Biosciences, Inc.
GlobeNewswire · Aug 27, 2026 12:50 PM
Financial Overview - Income Statement Quarterly

See ARGX's money flow as a full page

Social Sentiment
Avg +0.57 · 3 posts
TradeDiscussionDoes anyone else think Shorting Big Pharma could be the next million dollar play
r/investing · Dec 10, 2024
The post proposes shorting ARGX, signifying a negative outlook on its future performance.
negative +0.50
Biotech/Pharma FDA Catalysts Calendar for Early July 2024 along with Brief DD
r/stocks · Jul 2, 2024
The post provides detailed DD on ARGX's upcoming catalyst, indicating a positive outlook.
positive +0.60
DDNewsBiotech and Pharma FDA Catalysts Calendar for Early July 2024 with Unusual and Most Active Options
r/options · Jul 2, 2024
Focus on positive catalyst (Phase 2 data), market cap, and probability of approval.
positive +0.60
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙